行情

DXCM

DXCM

德康医疗
NASDAQ

实时行情|Nasdaq Last Sale

260.75
-5.63
-2.11%
已收盘, 19:14 04/03 EDT
开盘
263.62
昨收
266.38
最高
272.48
最低
257.07
成交量
108.13万
成交额
--
52周最高
306.71
52周最低
107.44
市值
238.83亿
市盈率(TTM)
240.74
分时
5日
1月
3月
1年
5年

分析师评级

19位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测DXCM价格均价为289.50,最高价位330.00,最低价为240.00。

EPS

DXCM 新闻

更多
  • 30 Top Stocks and Funds to Beat the COVID-19 Bear Market
  • MotleyFool.com · 12小时前
  • Eli Lilly, Vertex, Dexcom, Masimo, Veeva: 5 Medical Stocks In Good Health Amid Coronavirus Crisis
  • Investor's Business Daily · 1天前
  • Cramer's lightning round: Delta Air Lines is not a buy
  • CNBC.com · 2天前
  • Will DexCom (DXCM) Beat Estimates Again in Its Next Earnings Report?
  • Zacks · 2天前

所属板块

医疗设备、用品及经销
-0.92%
医疗设备和用品
-1.17%

热门股票

代码
价格
涨跌幅

DXCM 简况

Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. The Company's products consist of DexCom G4 PLATINUM and DexCom G5 Mobile. The Company is commercializing its fifth generation CGM system. The Company's markets DexCom G4 PLATINUM under a Conformite Europeenne Marking (CE Mark), in the European Union, Australia, New Zealand and the countries in Asia and Latin America, and in the United States with approval from the United States Food and Drug Administration (FDA). The DexCom G4 PLATINUM with Share remote monitoring system uses a wireless connection between a patient's receiver and an application on the patient's iPhone, iPod touch, or iPad to transmit glucose information to applications on the mobile devices of designated recipients (followers).
展开

微牛提供DexCom, Inc.(NASDAQ-DXCM)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的DXCM股票新闻,以帮助您做出投资决策。